Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
US4963525A · kind A · utility
14Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 1989 |
| Grant date | Oct 16, 1990 |
| Priority date | — |
| Expiry date | May 16, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/186
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Acylcarnitine used as a nasal, buccal, sublingual and vaginal drug absorption enhancing vehicle for poorly absorbed drugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.